Fujian Cancer Hospital
Clinical trials sponsored by Fujian Cancer Hospital, explained in plain language.
-
New hope for cancer patients forced off immunotherapy due to severe side effects
Disease control Not yet recruitingThis study tests a drug called ivarmacitinib in 72 adults with advanced solid tumors who had to stop immunotherapy because of serious immune-related side effects. The goal is to see if ivarmacitinib can control those side effects and allow some patients to safely restart their ca…
Phase: PHASE2 • Sponsor: Fujian Cancer Hospital • Aim: Disease control
Last updated Apr 26, 2026 20:02 UTC
-
Gut bacteria boost? new combo aims to improve liver cancer surgery outcomes
Disease control Not yet recruitingThis study tests whether taking a probiotic (Lactobacillus reuteri) before surgery, along with standard immunotherapy, helps people with liver cancer recover better and live longer. Forty adults with resectable liver cancer will be randomly assigned to receive either the probioti…
Phase: NA • Sponsor: Fujian Cancer Hospital • Aim: Disease control
Last updated Apr 26, 2026 20:01 UTC
-
New drug combo shows promise for rare esophageal cancer
Disease control Not yet recruitingThis study tests whether adding the drug serplulimab to standard chemotherapy before surgery can help shrink tumors in people with a rare type of esophageal cancer. About 15 adults with limited-stage small cell carcinoma of the esophagus will receive the combination, then have su…
Phase: PHASE2 • Sponsor: Fujian Cancer Hospital • Aim: Disease control
Last updated Apr 26, 2026 20:01 UTC